LKC Technologies

LKC Technologies’ devices are FDA-cleared and CE-marked for clinical use in functional eye testing. Their RETeval device has been widely adopted globally for early diagnosis and management of diabetic retinopathy and other retinal diseases. Over 1300 devices are in use worldwide by ophthalmologists, optometrists, and researchers. The company’s technology enables non-invasive, portable ERG/VEP testing without the need for pupil dilation or corneal contact. Clinical studies have demonstrated utility in earlier detection of disease progression compared to standard clinical exams. Devices are also used in veterinary ophthalmology research.